Eligibility for Intravenous Recombinant Tissue-Type Plasminogen Activator Within a Population-Reference-Cited by-同舟云学术

Eligibility for Intravenous Recombinant Tissue-Type Plasminogen Activator Within a Population

Published:2012-06 Issue:6 Volume:43 Page:1591-1595
ISSN:0039-2499
Container-title:Stroke
language:en
Short-container-title:Stroke

Author:

de los Ríos la Rosa Felipe¹,Khoury Jane¹,Kissela Brett M.¹,Flaherty Matthew L.¹,Alwell Kathleen¹,Moomaw Charles J.¹,Khatri Pooja¹,Adeoye Opeolu¹,Woo Daniel¹,Ferioli Simona¹,Kleindorfer Dawn O.¹

Affiliation:

1. From the Department of Neurology (F.d.l.R.l.R., B.M.K., M.L.F., P.K., O.A., D.W., S.F., D.O.K.), University of Cincinnati College of Medicine, Cincinnati, OH; Cincinnati Children's Hospital (J.K.), Cincinnati, OH; and the University of Cincinnati (K.A., C.J.M.), Cincinnati, OH.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)

Reference30 articles.

1. National US Estimates of Recombinant Tissue Plasminogen Activator Use

2. Recombinant Tissue-Type Plasminogen Activator Use for Ischemic Stroke in the United States

3. Number Needed to Treat to Benefit and to Harm for Intravenous Tissue Plasminogen Activator Therapy in the 3- to 4.5-Hour Window

4. Thrombolytic Therapy Within 3 to 6 Hours After Onset of Ischemic Stroke

5. Efficacy and Safety of Tissue Plasminogen Activator 3 to 4.5 Hours After Acute Ischemic Stroke

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MRI-based microthrombi detection in stroke with polydopamine iron oxide;Nature Communications;2024-06-13

2. A Randomized Controlled Trial of Tenecteplase Versus Standard of Care for Minor Ischemic Stroke with Proven Occlusion (TEMPO-2): Rational and design of a multicenter, randomized open-label clinical trial;International Journal of Stroke;2024-05-17

3. Editorial: Diversity in stroke omic(s) and epidemiology research: opportunities and challenges;Frontiers in Stroke;2024-05-13

4. Racial Disparities in Blood Pressure at Time of Acute Ischemic Stroke Presentation: A Population Study;Journal of the American Heart Association;2024-05-07

5. Modulation of Abundance and Location of High-Mobility Group Box 1 in Human Microglia and Macrophages under Oxygen–Glucose Deprivation;ACS Pharmacology & Translational Science;2024-02-27